Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katarzyna Wieczerzak
Establishing a Model for Assessing DNA Damage in Murine Brain Cells as a Molecular Marker of Chemotherapy-Associated Cognitive Impairment
Life Sciences
Genetics
Molecular Biology
Pharmacology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Related publications
Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment
Clinical Cancer Research
Cancer Research
Oncology
Filamin-A as a Marker and Target for DNA Damage Based Cancer Therapy
DNA Repair
Biochemistry
Cell Biology
Molecular Biology
Frontal Atrophy as a Marker for Dementia Conversion in Parkinson's Disease With Mild Cognitive Impairment
Human Brain Mapping
Nuclear Medicine
Radiology
Ultrasound Technology
Anatomy
Radiological
Neurology
Imaging
An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study
Scientific Reports
Multidisciplinary
The Long Amplicon Quantitative PCR for DNA Damage Assay as a Sensitive Method of Assessing DNA Damage in the Environmental Model, Atlantic Killifish (Fundulus Heteroclitus)
Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology
Cell Biology
Biochemistry
Medicine
Animal Science
Mutagenesis
Health
Aquatic Science
Zoology
Toxicology
Physiology
Brain Natriuretic Propeptide as a Marker of the Heart Damage in Metabolic Syndrome
Russian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Erratum To: S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise
Sports Medicine
Sports Medicine
Physical Therapy
Sports Science
Sports Therapy
Orthopedics
Medicine
Rehabilitation
Cognitive Change Questionnaire as a Method for Cognitive Impairment Screening
Dementia e Neuropsychologia
Gerontology
Geriatrics
Neurology
Sensory Systems
Cognitive Neuroscience
Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment
Neural Plasticity
Neurology
